Jane Street Group, LLC Celldex Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $384 Billion
  • Q1 2025

A detailed history of Jane Street Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 214,426 shares of CLDX stock, worth $4.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214,426
Previous 118,300 81.26%
Holding current value
$4.39 Million
Previous $2.15 Million 81.23%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$18.15 - $27.6 $2.34 Million - $3.56 Million
128,844 Added 150.55%
214,426 $3.89 Million
Q4 2024

Feb 14, 2025
SELL
$23.31 - $32.4 $2.05 Million - $2.85 Million
-88,088 Reduced 50.72%
85,582 $2.16 Million
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $534,087 - $742,325
-16,659 Reduced 8.75%
173,670 $5.9 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $440,556 - $572,346
13,448 Added 7.6%
190,329 $7.04 Million
Q1 2024

May 15, 2024
BUY
$35.22 - $51.88 $1.72 Million - $2.53 Million
48,720 Added 38.01%
176,881 $7.42 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $1.55 Million - $2.79 Million
68,747 Added 115.71%
128,161 $5.08 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $876,930 - $1.29 Million
34,457 Added 138.07%
59,414 $1.64 Million
Q2 2023

Aug 14, 2023
SELL
$30.29 - $38.28 $1.3 Million - $1.64 Million
-42,902 Reduced 63.22%
24,957 $846,000
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $857,327 - $1.17 Million
24,650 Added 57.05%
67,859 $2.44 Million
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $274,994 - $449,216
9,899 Added 29.72%
43,209 $1.93 Million
Q3 2022

Nov 14, 2022
SELL
$22.7 - $37.57 $3.23 Million - $5.34 Million
-142,196 Reduced 81.02%
33,310 $937,000
Q2 2022

Aug 16, 2022
BUY
$20.5 - $37.33 $1.99 Million - $3.62 Million
97,097 Added 123.83%
175,506 $4.73 Million
Q1 2022

May 17, 2022
BUY
$27.64 - $39.32 $1.55 Million - $2.21 Million
56,209 Added 253.19%
78,409 $2.67 Million
Q4 2021

Feb 15, 2022
BUY
$35.68 - $56.27 $355,087 - $559,999
9,952 Added 81.25%
22,200 $858,000
Q3 2021

Nov 16, 2021
SELL
$28.95 - $55.99 $1.26 Million - $2.45 Million
-43,688 Reduced 78.1%
12,248 $661,000
Q2 2021

Aug 16, 2021
BUY
$20.71 - $35.37 $757,406 - $1.29 Million
36,572 Added 188.87%
55,936 $1.87 Million
Q1 2021

May 18, 2021
SELL
$16.19 - $29.91 $239,093 - $441,710
-14,768 Reduced 43.27%
19,364 $399,000
Q4 2020

Feb 17, 2021
BUY
$14.99 - $22.75 $303,637 - $460,824
20,256 Added 145.98%
34,132 $598,000
Q2 2020

Aug 17, 2020
BUY
$1.61 - $13.41 $22,340 - $186,077
13,876 New
13,876 $180,000

Others Institutions Holding CLDX

# of Institutions
188
Shares Held
69.3M
Call Options Held
220K
Put Options Held
310K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $958M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email